Chimeric Antigen Receptor T-cell Therapy in Hematologic Malignancies and Patient-reported Outcomes: A Scoping Review

The inclusion of patient-reported outcome (PRO) measures in chimeric antigen receptor (CAR) T-cell therapy research is critical for understanding the impact of this novel approach from a unique patient standpoint. We performed a scoping review to map the available literature on the use of PRO measur...

Full description

Bibliographic Details

Published in:	HemaSphere
Main Authors:	Fabio Efficace, Laura Cannella, Francesco Sparano, Johannes M. Giesinger, Marco Vignetti, Frédéric Baron, Eduardo Bruera, Mario Luppi, Uwe Platzbecker
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000802